Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy

被引：64

作者：

Roberts, R

Sigwart, U

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Univ Hosp Geneva, Ctr Cardiol, Geneva, Switzerland

[3] Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland

来源：

CIRCULATION | 2005年 / 112卷 / 02期

关键词：

cardiomyopathy; hypertrophy; genetics; death; sudden; ablation; alcohol;

D O I：

10.1161/01.CIR.0000146788.30724.0A

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：293 / 296

页数：4

共 20 条

[1] Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy [J].

Arad, M ;

Benson, DW ;

Perez-Atayde, AR ;

McKenna, WJ ;

Sparks, EA ;

Kanter, RJ ;

McGarry, K ;

Seidman, JG ;

Seidman, CE .

JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) :357-362

[2]

Brugada R, 1997, J INVEST MED, V45, P542

[3] PLASMA-LEVELS OF ATRIAL-NATRIURETIC-PEPTIDE IN HYPERTROPHIC CARDIOMYOPATHY [J].

DERCHI, G ;

BELLONE, P ;

CHIARELLA, F ;

RANDAZZO, M ;

ZINO, V ;

VECCHIO, C .

AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (18) :1502-1504

[4] Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy - Results with respect to intraprocedural myocardial contrast echocardiography [J].

Faber, L ;

Seggewiss, H ;

Gleichmann, U .

CIRCULATION, 1998, 98 (22) :2415-2421

[5] Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH) - Catheter interventional treatment for hypertrophic obstructive cardiomyopathy [J].

Gietzen, FH ;

Leuner, CJ ;

Raute-Kreinsen, U ;

Dellmann, A ;

Hegselmann, J ;

Strunk-Mueller, C ;

Kuhn, HJ .

EUROPEAN HEART JOURNAL, 1999, 20 (18) :1342-1354

[6] Identification of a gene responsible for familial Wolff-Parkinson-White syndrome [J].

Gollob, MH ;

Green, MS ;

Tang, ASL ;

Gollob, T ;

Karibe, A ;

Roberts, R ;

Ahmad, F ;

Lozado, R ;

Shah, G ;

Fananapazir, L ;

Bachinski, LL ;

Roberts, R ;

Tapscott, T ;

Gonzales, O ;

Begley, D ;

Mohiddin, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (24) :1823-1831

[7] Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy [J].

Kai, H ;

Muraishi, A ;

Sugiu, Y ;

Nishi, H ;

Seki, Y ;

Kuwahara, F ;

Kimura, A ;

Kato, H ;

Imaizumi, T .

CIRCULATION RESEARCH, 1998, 83 (06) :594-601

[8] Nonsurgical septal reduction for symptomatic hypertrophic obstructive cardiomyopathy: The Baylor experience (1996-1999) [J].

Lakkis, N ;

Nagueh, S ;

Killip, D ;

Torre, G ;

Roberts, R ;

Spencer, W .

JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2000, 13 (03) :157-159

[9] Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy [J].

Lim, DS ;

Lutucuta, S ;

Bachireddy, P ;

Youker, K ;

Evans, A ;

Entman, M ;

Roberts, R ;

Marian, AJ .

CIRCULATION, 2001, 103 (06) :789-791

[10] EXPRESSION OF A MUTATION CAUSING HYPERTROPHIC CARDIOMYOPATHY DISRUPTS SARCOMERE ASSEMBLY IN ADULT FELINE CARDIAC MYOCYTES [J].

MARIAN, AJ ;

YU, QT ;

MANN, DL ;

GRAHAM, FL ;

ROBERTS, R .

CIRCULATION RESEARCH, 1995, 77 (01) :98-106

← 1 2 →